If you have been researching weight loss medications or metabolic health treatments, you have almost certainly heard of Ozempic. But what exactly is it, and how does it relate to GLP-1 therapy? Is there a difference between "GLP-1" and "Ozempic," or are they the same thing?
The answer matters for your health decisions, particularly in India where options and availability differ from Western markets.
Ozempic Is a Brand Name
The most important thing to understand: Ozempic is a brand name, not a drug category. Ozempic is the trade name for the active molecule semaglutide, manufactured by the pharmaceutical company Novo Nordisk.
Semaglutide itself is a GLP-1 receptor agonist - a class of peptide therapy that mimics the naturally occurring gut hormone Glucagon-Like Peptide-1. So "GLP-1" is the broader category, and Ozempic is one specific, branded product within that category.
The distinction matters because:
- There are multiple GLP-1 peptides beyond semaglutide (including tirzepatide, liraglutide, and others)
- The active molecule in physician-supervised compounded semaglutide programs is the same molecule as in Ozempic
- Brand-name products carry a significant price premium that has nothing to do with clinical efficacy
The GLP-1 Family: More Than Just Ozempic
The GLP-1 receptor agonist class includes several distinct molecules, each with different properties:
| Molecule | Brand Names | Dosing | Key Differentiator | |---|---|---|---| | Semaglutide | Ozempic, Wegovy, Rybelsus | Weekly injection or daily oral | Longest clinical track record | | Tirzepatide | Mounjaro, Zepbound | Weekly injection | Dual GIP/GLP-1 agonist, greater weight loss | | Liraglutide | Victoza, Saxenda | Daily injection | Older agent, shorter duration | | Dulaglutide | Trulicity | Weekly injection | Lower maximum weight loss |
When physicians and peptide programs discuss GLP-1 therapy, they are referring to this entire class, not specifically to Ozempic.
Is Ozempic Available in India?
Ozempic (brand-name semaglutide) has limited commercial availability in India and carries a high cost. For Indian patients seeking semaglutide therapy, physician-supervised compounded semaglutide programs represent the primary accessible route.
Compounded semaglutide uses the same active pharmaceutical ingredient as Ozempic, formulated under regulated conditions and prescribed by a licensed physician. The therapeutic outcome is clinically equivalent when properly sourced and dosed.
Why "GLP-1 Therapy" Is the More Useful Frame
Thinking in terms of GLP-1 therapy rather than just Ozempic opens up more clinically appropriate choices:
- Peptide selection: A physician may recommend tirzepatide over semaglutide based on your metabolic profile, a choice you miss if you are fixated on one brand
- Dosing flexibility: Compounded programs allow for more granular dose titration than fixed-pen brand products
- Biomarker integration: GLP-1 therapy at Longegra includes comprehensive metabolic panel testing before and during the program, which branded retail programs rarely include
- Cost: Physician-supervised compounding delivers equivalent active molecules at a fraction of the brand-name price
What Matters Most: Supervision, Quality, and Monitoring
Whether you use semaglutide, tirzepatide, or another GLP-1 peptide, the most important variables are:
- Source quality: Pharmaceutical-grade active pharmaceutical ingredients from a regulated compounding facility
- Physician oversight: A licensed clinician assessing your suitability, prescribing appropriately, and adjusting your protocol
- Biomarker tracking: Regular lab work to confirm the therapy is producing the desired metabolic changes safely
At Longegra, all three of these are built into every GLP-1 program from day one.
Frequently Asked Questions (FAQs)
Yes. Ozempic is a branded version of semaglutide. The active molecule is identical.
